Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration

Journal of the American College of Cardiology

Volumn 60, Issue 21, 2012, Pages 2237-2249

  Kang, Kai ^a,b   Sun, Lu ^a,b   Xiao, Yun ^c   Li, Shu Hong ^b   Wu, Jun ^b   Guo, Jian ^b   Jiang, Shu Ling ^a   Yang, Lei ^a   Yau, Terrence M ^b   Weisel, Richard D ^b   Radisic, Milica ^c   Li, Ren Ke ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

bFGF; cardiac patch; cytokines; mesenchymal stromal cells; myocardial infarction; surgical ventricular restoration; VEGF

Indexed keywords

BIOMATERIAL; COLLAGEN; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; PROTEIN P16; VASCULOTROPIN; TISSUE SCAFFOLD;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABLE IMPLANT; CARDIOVASCULAR PROCEDURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ELASTIC TISSUE; HEART INFARCTION; HEART VENTRICLE FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STROMA CELL; NONHUMAN; P16 GENE; PRIORITY JOURNAL; RAT; SURGICAL VENTRICULAR RESTORATION; TISSUE ENGINEERING; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; DISEASE MODEL; HEART MUSCLE; HEART SURGERY; HEART VENTRICLE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REJUVENATION;

AGED; ANIMALS; BIOCOMPATIBLE MATERIALS; CARDIAC SURGICAL PROCEDURES; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; HEART VENTRICLES; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; REJUVENATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84869070573     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.08.985     Document Type: Article

References (30)

1. D. Lloyd-Jones, R.J. Adams, T.M. Brown Heart disease and stroke statistics - 2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
2. M. Di Donato, F. Fantini, A. Toso Impact of surgical ventricular reconstruction on stroke volume in patients with ischemic cardiomyopathy J Thorac Cardiovasc Surg 140 2010 1325 1331
3. R.H. Jones, E.J. Velazquez, R.E. Michler Coronary bypass surgery with or without surgical ventricular reconstruction N Engl J Med 360 2011 1705 1717
4. T. Nomoto, T. Nishina, S. Miwa Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats Circulation 106 2002 I115 I119
5. M. Tsukashita, A. Marui, T. Nishina Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery J Thorac Cardiovasc Surg 136 2008 58 64
6. H. Tsuneyoshi, T. Nishina, T. Nomoto Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair Circulation 110 2011 II174 II179
7. T. Nishina, K. Nishimura, S. Yuasa Initial effects of the left ventricular repair did not last long in a rat ischemic cardiomyopathy model Circulation 104 2001 I241 I245
8. T. Ozawa, D.A. Micke, R.D. Weisel Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats J Thorac Cardiovasc Surg 124 2002 1157 1164 (Pubitemid 35417003)
9. K. Matsubayashi, P.W. Fedak, D.A. Micke, R.D. Weisel, T. Ozawa, R.K. Li Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts Circulation 108 2003 II219 II225
10. Y. Sakakibara, K. Tambara, F. Lu Combined procedure of surgical repair and cell transplantation for left ventricular aneurysm: an experimental study Circulation 106 2002 I193 I197
11. L.L. Chiu, M. Radisic Scaffolds with covalently immobilized VEGF and angiopoietin-1 for vascularization of engineered tissues Biomaterials 31 2010 226 241
12. Y. Miyagi, L.L. Chiu, M. Cimini, R.D. Weisel, M. Radisic, R.K. Li Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair Biomaterials 32 2011 1280 1290
13. T. Shin'oka, G. Matsumura, N. Hibino Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells J Thorac Cardiovasc Surg 129 2005 1330 1338
14. C. Heeschen, R. Lehmann, J. Honold Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease Circulation 109 2004 1615 1622 (Pubitemid 38451717)
15. H. Zhang, S. Fazel, H. Tian Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy Am J Physiol Heart Circ Physiol 289 2005 H2089 H2096
16. Y. Miyagi, F. Zeng, X.P. Huang Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold Biomaterials 31 2010 7684 7694
17. T. Fujita, T. Shirasawa, N. Maruyama Expression and structure of senescence marker protein-30 (SMP30) and its biological significance Mech Ageing Dev 107 1999 271 280 (Pubitemid 29210229)
18. K.R. Shibata, T. Aoyama, Y. Shima Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion Stem Cells 25 2007 2371 2382 (Pubitemid 47480497)
19. R.K. Jain, P. Au, J. Tam, D.G. Duda, D. Fukumura Engineering vascularized tissue Nat Biotechnol 23 2005 821 823 (Pubitemid 43093121)
20. M. Radisic, H. Park, F. Chen Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds Tissue Eng 12 2006 2077 2091 (Pubitemid 44734968)
21. M.A. Brown, R.K. Iyer, M. Radisic Pulsatile perfusion bioreactor for cardiac tissue engineering Biotechnol Prog 24 2008 907 920
22. K.Y. Lee, M.C. Peters, K.W. Anderson, D.J. Mooney Controlled growth factor release from synthetic extracellular matrices Nature 408 2000 998 1000 (Pubitemid 32101648)
23. P.R. Vale, D.W. Losordo, C.E. Milliken Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia Circulation 102 2000 974
24. R.D. Kenagy, C.E. Hart, W.G. Stetler-Stevenson, A.W. Clowes Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9 Circulation 96 1997 3555 3560 (Pubitemid 27513433)
25. D.W. Losordo, S. Dimmeler Therapeutic angiogenesis and vasculogenesis for ischemic disease Part I: angiogenic cytokines Circulation 109 2004 2487 2491 (Pubitemid 38720544)
26. T.A. Spanholtz, P. Theodorou, T. Holzbach, S. Wutzler, R.E. Giunta, H.G. Machens Vascular endothelial growth factor (VEGF165) plus basic fibroblast growth factor (bFGF) producing cells induce a mature and stable vascular network-a future therapy for ischemically challenged tissue J Surg Res 171 2011 329 338
27. T. Asahara, C. Bauters, L.P. Zheng Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo Circulation 92 1995 II365 II371
28. S.F. Badylak The extracellular matrix as a biologic scaffold material Biomaterials 28 2007 3587 3593 (Pubitemid 46855878)
29. Z.Q. Zhao, J.D. Puskas, D. Xu Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction J Am Coll Cardiol 55 2010 1250 1261
30. S.F. Badylak, D.J. Weiss, A. Caplan, P. Macchiarini Engineered whole organs and complex tissues Lancet 379 2012 943 952